Experimental Drug Found to Reduce High Blood Pressure in Diabetics and Hypertensive Patients

An experimental drug, empagliflozin, developed for treating Type 2 diabetes has been found to lower blood pressure in diabetic and hypertensive patients, a new study presented at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago reveals. This improvement in blood pressure reportedly was accompanied by a reduction in blood glucose (sugar) levels after 12 weeks of treatment with the drug, which is under ...

Read More